(Q36315174)

13 August 2017

1 reference

title

Central venous access devices in patients with hemophilia (English)

1 reference

13 August 2017

0 references

Leonard A Valentino

1

1 reference

13 August 2017

Mukesh Kapoor

series ordinal

2

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Expert Review of Medical Devices

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

699-711

1 reference

The hemophilias--from royal genes to gene therapy

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Consensus recommendations for use of central venous access devices in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Status of practice guidelines in the United States: CDC guidelines as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Long-term central venous access

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Central venous catheters in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Central venous lines in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

The Malmö model for immune tolerance induction: impact of previous treatment on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Home management of haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Hemophilia home treatment. Economic analysis and implications for health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Central venous access devices in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

A boarding school for hemophiliacs: a model for the comprehensive care of hemophilic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Aids for hemophiliac children on a self-infusion program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

The role of self-infusion treatment for the patient with haemophilia (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Totally implantable venous access systems in paediatric practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Subcutaneous infusion ports in the pediatric patient with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Hemophilia management: optimizing treatment based on patient needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Surveillance of infectious complications associated with central venous access devices in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

The use of central venous catheters (portacaths) in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

The use of the Port-A-Cath in children with haemophilia--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

The use of implantable venous access devices (IVADs) in children with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Complications of central venous catheters in patients with haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Haemophilia and advanced fibrin sealant technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Complications experienced with central venous catheters in children with congenital bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Complications of central venous access devices in paediatric haemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Septic arthritis in hemophilia with central venous catheter: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Use of central venous catheters in children with severe congenital coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Results of secondary prophylaxis in children with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

A prospective clinical trial of implantable central venous access in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Central venous catheter-associated thrombosis in severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Experience of prophylaxis treatment in children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Use of antibiotic locks to treat colonized central venous catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Thrombotic complications of central venous catheters in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Contrast venography in young haemophiliacs with implantable central venous access devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Treatment of occluded central venous catheters with alteplase: results in 1,064 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Complications associated with the use of central venous access devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Central venous catheter use. Part 2: infectious complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

The promise and challenges of bioengineered recombinant clotting factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

New high-technology products for the treatment of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Novel delivery systems for coagulation proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2.6.699

21 January 2018

Identifiers

DOI

10.1586/17434440.2.6.699

1 reference

13 August 2017

1 reference